-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
SARS-CoV-2-3CLpro-IN-4
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/2505241-31-4.gif)
| Category | SARS-CoV |
| CAS | 2505241-31-4 |
| Description | SARS-CoV-2 3CLpro-IN-4 (Compound 5g) is a SARS CoV-2 3CLpro inhibitor with antiviral, antibacterial and antifungal activities. |
Product Information
| Synonyms | SARS-CoV-2 3CLpro-IN-4|HY-147805 |
| Molecular Weight | 450.94 |
| Molecular Formula | C22H19ClN6OS |
| Canonical SMILES | CC(=O)C(=NNC1=CC(=CC=C1)Cl)SC(=NNC2=CC=CC=C2)N=NC3=CC=CC=C3 |
| Purity | ≥98% (HPLC) |
| Solubility | In vitro: 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| Complexity | 658 |
| Exact Mass | 450.1029581 |
| Target | SARS-CoV; Bacterial; Fungal |
| XLogP3-AA | 8 |
